Cohance Lifesciences Ltd.
COHANCE Share PricePharmaceuticals & Drugs
₹1,012.95
90.1 (9.8%)
As on September 8, 2025
Exchange Scrips: BSE543064NSECOHANCEISININE03QK01018
Market Cap ₹ 38,067 Cr
P/E Ratio 96.28
Dividend Yield N/A
Performance
Market performance
Open937.7
High1,038.9
Volumes49,38,667
Prev1,012.95
Low914.25
As on2025-09-08
Historical performance
1 Year High1,360
3 Year High1,360
5 Year High1,360
1 Year Low856.3
3 Year Low390.5
5 Year Low291.6
Fundamentals
Company Valuation
Market Cap (₹Cr)
38,067
Face Value (₹)
1
P/E Ratio
96.28
Dividend Yield
N/A
Investment Returns
1 Year
-15.6%
3 Years
106.1%
5 Years
200.9%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 929.95 | Bullish |
| 10-DMA | 908.03 | Bullish |
| 20-DMA | 915.04 | Bullish |
| 50-DMA | 970.89 | Bullish |
| 100-DMA | 1,022.31 | Bearish |
| 200-DMA | 1,087.87 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 2 | 1 | 1 | 1 | 1 |
| Foreign Investors | 2 | 1 | 1 | 1 | 1 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 80908 | 86324 | 84209 | 69336 | 65776 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 96.28.
- 3Y Stock Price CAGR of the stock is 28.5.
- The stock has a beta of 0.5.
- In the last financial year, the company had an EBITDA of ₹4338 Million.
- The company generated revenue of ₹11976 Million in the previous financial year.
Cohance Lifesciences Ltd.
1012.9590.1 (9.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 839925.4
No. of Shares: 829 (Approx)
Performance:-16%
P/L: ₹-160074.6
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent